EVENT
Αύγουστος
30
2014
30 Αuγ 2014 12:00 PM • 03 Σεπ 2014 12:00 PM • Barcelona
ESC Congress 2014
Boehringer Ingelheim is excited to be attending the ESC Congress 2014, organised by the European Society of Cardiology in Barcelona, the world’s largest and most influential cardiovascular event.
During this year’s congress, data on Pradaxa® for the treatment of a broad range of thromboembolic diseases will be presented, including two Hot line sessions, which will provide further clinical insights and help inform future anticoagulation treatment decisions.
The ESC Congress 2014 marks five years since the study results from the landmark RE-LY® trial were presented at the ESC Congress 2009, also in Barcelona. Since then, the RE-LY® findings have been reconfirmed in numerous sub-analyses and supported by Regulatory Authorities worldwide.